SRGAP1
Basic information
Region (hg38): 12:63843761-64162217
Links
Phenotypes
GenCC
Source:
- thyroid cancer, nonmedullary, 2 (No Known Disease Relationship), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (92 variants)
- not_provided (31 variants)
- SRGAP1-related_disorder (20 variants)
- Thyroid_cancer,_nonmedullary,_2 (8 variants)
- Congenital_anomaly_of_kidney_and_urinary_tract (3 variants)
- Nephronophthisis (1 variants)
- Congenital_anomalies_of_kidney_and_urinary_tract_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRGAP1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020762.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 16 | 23 | ||||
| missense | 104 | 109 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 0 | 106 | 18 | 9 |
Highest pathogenic variant AF is 0.000007532616
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SRGAP1 | protein_coding | protein_coding | ENST00000355086 | 22 | 303541 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.998 | 0.00155 | 125729 | 0 | 17 | 125746 | 0.0000676 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.21 | 454 | 607 | 0.748 | 0.0000330 | 7204 |
| Missense in Polyphen | 90 | 150.86 | 0.59656 | 1767 | ||
| Synonymous | 1.39 | 202 | 229 | 0.883 | 0.0000130 | 2019 |
| Loss of Function | 5.81 | 8 | 54.1 | 0.148 | 0.00000293 | 654 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000120 | 0.000120 |
| Ashkenazi Jewish | 0.0000993 | 0.0000992 |
| East Asian | 0.000110 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000719 | 0.0000703 |
| Middle Eastern | 0.000110 | 0.000109 |
| South Asian | 0.000131 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42. {ECO:0000269|PubMed:11672528}.;
- Disease
- DISEASE: Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms. {ECO:0000269|PubMed:23539728}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;Signal Transduction;Rho GTPase cycle;Inactivation of CDC42 and RAC1;Signaling by Rho GTPases;Signaling by ROBO receptors;Axon guidance;Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.610
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 12.01
Haploinsufficiency Scores
- pHI
- 0.370
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.503
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Srgap1
- Phenotype
Gene ontology
- Biological process
- signal transduction;negative regulation of cell migration;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction
- Cellular component
- cytoplasm;cytosol
- Molecular function
- GTPase activator activity;protein binding;Rac GTPase binding